Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · IEX Real-Time Price · USD
1.440
0.00 (0.00%)
At close: Apr 24, 2024, 4:00 PM
1.400
-0.040 (-2.78%)
Pre-market: Apr 25, 2024, 8:02 AM EDT
Marinus Pharmaceuticals Market Cap
Marinus Pharmaceuticals has a market cap or net worth of $78.69 million as of April 25, 2024. Its market cap has decreased by -80.22% in one year.
Market Cap
78.69M
Enterprise Value
37.35M
1-Year Change
-80.22%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since July 31, 2014, Marinus Pharmaceuticals's market cap has decreased from $97.90M to $78.69M, a decrease of -19.63%. That is a compound annual growth rate of -2.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 78.70M | -2.36% |
Apr 22, 2024 | 80.60M | 6.90% |
Apr 19, 2024 | 75.40M | -2.08% |
Apr 18, 2024 | 77.00M | -2.16% |
Apr 17, 2024 | 78.70M | 19.97% |
Apr 16, 2024 | 65.60M | -7.61% |
Apr 15, 2024 | 71.00M | -82.72% |
Apr 12, 2024 | 410.90M | -5.06% |
Apr 11, 2024 | 432.80M | -2.10% |
Apr 10, 2024 | 442.10M | -3.45% |
Apr 9, 2024 | 457.90M | 2.19% |
Apr 8, 2024 | 448.10M | 5.14% |
Apr 5, 2024 | 426.20M | -10.14% |
Apr 4, 2024 | 474.30M | -0.23% |
Apr 3, 2024 | 475.40M | -1.92% |
Apr 2, 2024 | 484.70M | -1.10% |
Apr 1, 2024 | 490.10M | -0.79% |
Mar 28, 2024 | 494.00M | 2.15% |
Mar 27, 2024 | 483.60M | 0.69% |
Mar 26, 2024 | 480.30M | -1.58% |
Mar 25, 2024 | 488.00M | 1.37% |
Mar 22, 2024 | 481.40M | -2.21% |
Mar 21, 2024 | 492.30M | -0.34% |
Mar 20, 2024 | 494.00M | -2.79% |
Mar 19, 2024 | 508.20M | 3.10% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chimerix | 80.82M |
InflaRx | 80.08M |
Oncolytics Biotech | 79.94M |
Tiziana Life Sciences | 79.48M |
CEL-SCI | 78.81M |
Cognition Therapeutics | 77.61M |
Athira Pharma | 77.04M |
Palisade Bio | 77.02M |